Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience License Partner Sells Petra01-Project To Hibercell

March 8 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * LICENSE PARTNER HAS SOLD PETRA01-PROJECT TO HIBERCELL
    * LICENCE AGREEMENT WITH CO STAYS UNCHNAGED AFTER
TRANSACTION
    * PARTNER RAVENNA PHARMACEUTICALS SELLS PETRA01-PROJECT TO
HIBERCELL

Source text for Eikon:  ID:nWkr37DmT 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sprint Bioscience AB

See all news